Quantcast
Channel: Endpoints News
Viewing all articles
Browse latest Browse all 5891

Prime Medicine CSO departs, reveals new funding; FDA lifts partial hold on Kezar drug

$
0
0
Plus, news about OKYO Pharma, Modi Ventures and BriaCell Therapeutics: More changes at Prime Medicine: The biotech said Chief Scientific Officer Jeremy Duffield is leaving the company. It also announced up ...

Viewing all articles
Browse latest Browse all 5891

Trending Articles